Lower IGFBP-1 Plasma Levels in Mothers of Autistic Children
IGF-I is an important growth factor and hormone which regulates protein turnover as well as having potent mitogenic and differentiating
effects on most cell types.IGF binding proteins (IGFBP) act as carrier proteins and regulators by controlling bioavailability of IGF-I to tissues. We
used immune-arrays to measure IGFBP-1in mothers of autistic children and found that the levels were significantly lower than levels in mothers
of non-autistic children. IGF has been found to be decreased in autism. We suggest that these low levels are associated with low maternal IGFBP-1. Fetal growth is controlled by genetic, environmental, and nutritional factors. The non-genetic elements become increasingly
important in the second half of pregnancy and contribute to the
natural phenomenon of maternal constraint on the size of the baby,
so overriding paternal genetic influences. IGF-I is an important
growth factor and hormone which regulates protein turnover as
well as having potent mitogenic and differentiating effects on most
cell types. In mothers whose pregnancies incur fetal growth restriction (FGR) IGF-I concentrations are greatly reduced.1
There are at
least seven IGF binding proteins (IGFBP) that act not only as carrier
proteins but also as regulators by controlling bioavailability of IGF-I
to tissues. IGFBP-1 (synonymous with placental protein 12 and human pregnancy-associated endometrial α-1 globulin) has a molecular weight of 25 kilo Daltons and binds IGF-I to form a 34 kilo Dalton
complex. This complex can cross intact endothelium and so may be
involved in delivery of IGF-I to the tissues. Although in theory this
could enhance IGF-I availability, IGFBP-1 inhibits IGF-I action in
most in vitro systems and in blood. Several observations suggest
that maternal IGFBP-1 is important in pregnancy. Concentrations
usually rise rapidly in the first 12 weeks of pregnancy, and then remain high until delivery.2,3 Low IGFBP-1 has been associated with
diabetes.4 IGFBP-1 is closely involved in carbohydrate metabolism,5
being regulated by insulin.6
In this study, we measured IGFBP-1 levels in mothers of individuals with autism and neurotypical, age and
gender similar controls. We found that IGFBP-1 levels were significantly lower in the maternal autistic group.
https://www.stephypublishers.com/sojpcn/pdf/SOJPCN.MS.ID.000516.pdf
Comments
Post a Comment